1.Bruno de Benoist, E. M., Ines Egli, Mary Cogswell, Worldwide prevalence of anaemia 1993–2005 WHO Global Database on Anaemia. World Health Organization: 2008.
2.Shaw, N. S.; Yeh, W. T..; Pan, W. H.; Prevalence of iron deficiency in the general population in Taiwan. Nutritional Sciences 1999, 24 (1), 20.
3.中醫藥委員會, 當歸補血湯之組成. http://www.ccmp.gov.tw/information/formula_detail.asp?no=194&selno=0&relno=549.
4.聶克, 當歸補血湯考. 中成藥 1996, 1 (1), 1.
5.范穎,陳信義, 當歸補血湯源流及配伍效用關係研究進展. 中國實驗方劑學雜誌 2006, 12 (10), 5.
6.Yang, M.; Chan, G. C.; Deng, R.; Ng, M. H.; Cheng, S. W.; Lau, C. P.; Ye, J. Y.; Wang, L.; Liu, C., An herbal decoction of Radix astragali and Radix angelicae sinensis promotes hematopoiesis and thrombopoiesis. J Ethnopharmacol 2009, 124 (1), 87-97.
7.Dong, T. T.; Zhao, K. J.; Gao, Q. T.; Ji, Z. N.; Zhu, T. T.; Li, J.; Duan, R.; Cheung, A. W.; Tsim, K. W., Chemical and biological assessment of a chinese herbal decoction containing Radix Astragali and Radix Angelicae Sinensis: Determination of drug ratio in having optimized properties. J Agric Food Chem 2006, 54 (7), 2767-74.
8.Gao, Q. T.; Cheung, J. K.; Li, J.; Jiang, Z. Y.; Chu, G. K.; Duan, R.; Cheung, A. W.; Zhao, K. J.; Choi, R. C.; Dong, T. T.; Tsim, K. W., A Chinese herbal decoction, Danggui Buxue Tang, activates extracellular signal-regulated kinase in cultured T-lymphocytes. FEBS Lett 2007, 581 (26), 5087-93.
9.金若敏,寧燦,陳長勛,孫崢嶸,孫成立,胡之璧, 血虛模型動物製備及當歸補血湯作用的研究. 中成藥 2001, 23 (4), 4.
10.張戰平,張遠炎,姚並軍, 氣虛症患者免疫球蛋白和補體水平測定. 成都中醫藥大學學報 2000, 23 (1), 2.
11.Yuan, G. H.; Pang, X. J.; Ma, H. C., [Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice]. Zhong Xi Yi Jie He Xue Bao 2008, 6 (1), 83-8.
12.陳雲華,孫建寧, 當歸補血湯對急性缺氧小鼠紅細胞功能的影響. 中國實驗方劑學雜誌 2006, 12 (10), 3.
13.Zhang, X. L.; Yu, X. H.; Tang, X. Y.; Song, B. H.; Ling, H.; Liu, Y. W.; Wang, Z. L., Prophylactic immunization of dangguibuxue decoction against Cryptosporidium infection in immune suppressed mice. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2008, 26 (3), 179-82.
14.Gao, Q. T.; Cheung, J. K.; Choi, R. C.; Cheung, A. W.; Li, J.; Jiang, Z. Y.; Duan, R.; Zhao, K. J.; Ding, A. W.; Dong, T. T.; Tsim, K. W., A Chinese herbal decoction prepared from Radix Astragali and Radix Angelicae Sinensis induces the expression of erythropoietin in cultured Hep3B cells. Planta Med 2008, 74 (4), 392-5.
15.行政院衛生署, 中華中藥典. 行政院衛生署: 台北, 民國93年.
16.Liu, J.; Hu, X.; Yang, Q.; Yu, Z.; Zhao, Z.; Yi, T.; Chen, H., Comparison of the immunoregulatory function of different constituents in radix astragali and radix hedysari. J Biomed Biotechnol 2010, 479426.
17.顏焜熒, 原色常用中藥圖鑑. 台北南天書局: 民國88年.18.Deng, Y.; Chen, H. F., [Effects of Astragalus injection and its ingredients on proliferation and Akt phosphorylation of breast cancer cell lines]. Zhong Xi Yi Jie He Xue Bao 2009, 7 (12), 1174-80.
19.Zhao, Z.; Wang, W.; Wang, F.; Zhao, K.; Han, Y.; Xu, W.; Tang, L., Effects of Astragaloside IV on heart failure in rats. Chin Med 2009, 4, 6.
20.Wang, S.; Li, J.; Huang, H.; Gao, W.; Zhuang, C.; Li, B.; Zhou, P.; Kong, D., Anti-hepatitis B virus activities of astragaloside IV isolated from radix Astragali. Biol Pharm Bull 2009, 32 (1), 132-5.
21.Zhu, S. Q.; Qi, L.; Rui, Y. F.; Li, R. X.; He, X. P.; Xie, Z. P., Astragaloside IV inhibits spontaneous synaptic transmission and synchronized Ca2+ oscillations on hippocampal neurons. Acta Pharmacol Sin 2008, 29 (1), 57-64.
22.Kim, J. H.; Kim, M. R.; Lee, E. S.; Lee, C. H., Inhibitory effects of calycosin isolated from the root of Astragalus membranaceus on melanin biosynthesis. Biol Pharm Bull 2009, 32 (2), 264-8.
23.Wu, X. L.; Wang, Y. Y.; Cheng, J.; Zhao, Y. Y., Calcium channel blocking activity of calycosin, a major active component of Astragali Radix, on rat aorta. Acta Pharmacol Sin 2006, 27 (8), 1007-12.
24.Sterk, M.; Muller, J.; Hemphill, A.; Muller, N., Characterization of a Giardia lamblia WB C6 clone resistant to the isoflavone formononetin. Microbiology 2007, 153 (Pt 12), 4150-8.
25.Castelluccio, C.; Bolwell, G. P.; Gerrish, C.; Rice-Evans, C., Differential distribution of ferulic acid to the major plasma constituents in relation to its potential as an antioxidant. Biochem J 1996, 316 ( Pt 2), 691-4.
26.Wang, J.; Sun, B.; Cao, Y.; Tian, Y., Protection of wheat bran feruloyl oligosaccharides against free radical-induced oxidative damage in normal human erythrocytes. Food Chem Toxicol 2009, 47 (7), 1591-9.
27.Wang, S.; Gao, Z.; Chen, X.; Lian, X.; Zhu, H.; Zheng, J.; Sun, L., The anticoagulant ability of ferulic acid and its applications for improving the blood compatibility of silk fibroin. Biomed Mater 2008, 3 (4), 044106.
28.Ardiansyah; Ohsaki, Y.; Shirakawa, H.; Koseki, T.; Komai, M., Novel effects of a single administration of ferulic acid on the regulation of blood pressure and the hepatic lipid metabolic profile in stroke-prone spontaneously hypertensive rats. J Agric Food Chem 2008, 56 (8), 2825-30.
29.Kuang, X.; Yao, Y.; Du, J. R.; Liu, Y. X.; Wang, C. Y.; Qian, Z. M., Neuroprotective role of Z-ligustilide against forebrain ischemic injury in ICR mice. Brain Res 2006, 1102 (1), 145-53.
30.Zhang, L.; Du, J. R.; Wang, J.; Yu, D. K.; Chen, Y. S.; He, Y.; Wang, C. Y., Z-ligustilide extracted from Radix Angelica Sinensis decreased platelet aggregation induced by ADP ex vivo and arterio-venous shunt thrombosis in vivo in rats. Yakugaku Zasshi 2009, 129 (7), 855-9.
31.肖西峰,謝麗,金凡,閔保華, 當歸精油治療痛經的機制研究. 陝西醫學雜誌 2008, 37 (2), 3.
32.衛生署食品局, 健康食品之促進鐵吸收功能評估方法; 台北市, 2009.
33.何敏夫, 血液學(Hematology) 合記出版社; 台北市, 2008.
34.Borch-Iohnsen, B.; Hagve, T. A.; Hauge, A.; Thorstensen, K., [Regulation of the iron metabolism]. Tidsskr Nor Laegeforen 2009, 129 (9), 858-62.
35.MICROMEDEX® 1.0 (Healthcare Series)
36.Andrews, N. C., Disorders of iron metabolism. N Engl J Med 1999, 341 (26), 1986-95.
37.行政院衛生署, 國人膳食營養素參考攝取量. 第六版修訂; 台北市, 2003.
38.Ekman, M.; Reizenstein, P., Comparative absorption of ferrous and heme-iron with meals in normal and iron deficient subjects. Z Ernahrungswiss 1993, 32 (1), 67-70.
39.Kim, E. Y.; Ham, S. K.; Shigenaga, M. K.; Han, O., Bioactive dietary polyphenolic compounds reduce nonheme iron transport across human intestinal cell monolayers. J Nutr 2008, 138 (9), 1647-51.
40.Jin, F.; Frohman, C.; Thannhauser, T. W.; Welch, R. M.; Glahn, R. P., Effects of ascorbic acid, phytic acid and tannic acid on iron bioavailability from reconstituted ferritin measured by an in vitro digestion-Caco-2 cell model. Br J Nutr 2009, 101 (7), 972-81.
41.Hurrell, R. F.; Reddy, M.; Cook, J. D., Inhibition of non-haem iron absorption in man by polyphenolic-containing beverages. Br J Nutr 1999, 81 (4), 289-95.
42.Glahn, R. P.; Lee, O. A.; Yeung, A.; Goldman, M. I.; Miller, D. D., Caco-2 cell ferritin formation predicts nonradiolabeled food iron availability in an in vitro digestion/Caco-2 cell culture model. J Nutr 1998, 128 (9), 1555-61.
43.Marcel E Conrad, M., (Retired) Distinguished Professor of Medicine, University of South Alabama Iron Deficiency Anemia. http://emedicine.medscape.com/article/202333-overview.
44.吳燕平, 中西藥聯用的探討. 海峽藥學 2007, 19 (12), 2.
45.陳逸生,張坤水, 中西藥聯用的配伍禁忌及相互作用分析. 中國現代藥物應用 2008, 2 (5), 2.
46.Jumarie, C.; Malo, C., Caco-2 cells cultured in serum-free medium as a model for the study of enterocytic differentiation in vitro. J Cell Physiol 1991, 149 (1), 24-33.
47.Wood, R. J.; Han, O., Recently identified molecular aspects of intestinal iron absorption. J Nutr 1998, 128 (11), 1841-4.
48.衛生署中醫藥委員會 http://www.ccmp.gov.tw/index.asp.
49.Hynes, M. J.; O''Coinceanainn, M., The kinetics and mechanisms of reactions of iron(III) with caffeic acid, chlorogenic acid, sinapic acid, ferulic acid and naringin. J Inorg Biochem 2004, 98 (8), 1457-64.
50.Polubesova, T.; Eldad, S.; Chefetz, B., Adsorption And Oxidative Transformation Of Phenolic Acids By Fe(III)-Montmorillonite. Environ Sci Technol 44 (11), 4203-9.